Decrease in the synthesis and release of calcitonin gene-related peptide in dorsal root ganglia of spontaneously hypertensive rat: Role of nitric oxide synthase inhibitors

European Journal of Pharmacology

Volumn 596, Issue 1-3, 2008, Pages 132-137

  Chen, Qing Quan ^a   Li, Dai ^a   Guo, Ren ^a   Luo, Dan ^a   Yang, Jing ^a   Hu, Chang Ping ^a   Li, Yuan Jian ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Asymmetric dimethylarginine; Calcitonin gene related peptide; Dorsal root ganglia neural cells; Hypertension; Nitric oxide

Indexed keywords

3,3 BIS(2 AMINOETHYL) 1 HYDROXY 2 OXOTRIAZENE; ARGININE; CALCITONIN GENE RELATED PEPTIDE; N(G),N(G) DIMETHYLARGININE; NITRIC OXIDE; NITRIC OXIDE DONOR; NITRIC OXIDE SYNTHASE INHIBITOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD LEVEL; BLOOD PRESSURE REGULATION; CONCENTRATION (PARAMETERS); CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATION ANALYSIS; CULTURE MEDIUM; HYPERTENSION; IN VITRO STUDY; IN VIVO STUDY; MALE; NERVE CELL CULTURE; NEUROTRANSMITTER RELEASE; NONHUMAN; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN SECRETION; RAT; REGULATORY MECHANISM; SPINAL GANGLION; SPONTANEOUSLY HYPERTENSIVE RAT; SYSTOLIC BLOOD PRESSURE; WISTAR KYOTO RAT;

ANIMALS; ARGININE; BLOOD PRESSURE; CALCITONIN GENE-RELATED PEPTIDE; CELLS, CULTURED; GANGLIA, SPINAL; NITRIC OXIDE; NITRIC OXIDE DONORS; NITRIC OXIDE SYNTHASE; NITROSO COMPOUNDS; RATS; RATS, INBRED SHR; RATS, INBRED WKY; RATS, SPRAGUE-DAWLEY; SPECIES SPECIFICITY;

EID: 53049106721     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2008.08.029     Document Type: Article

References (45)

1. Achan V., Broadhead M., Malaki M., Whitley G., Leiper J., MacAllister R., and Vallance P. Asymmetric dimethylarginine causes hypertension and cardiac dysfunction in humans and is actively metabolized by dimethylarginine dimethylaminohydrolase. Arterioscler. Thromb. Vasc. Biol. 23 (2003) 1455-1459
2. Bell D., and McDermott B.J. Calcitonin gene-related peptide in the cardiovascular system: characterization of receptor populations and their (patho)physiological significance. Pharmacol. Rev. 48 (1996) 253-288
3. Beltowski J., and Kedra A. Asymmetric dimethylarginine (ADMA) as a target for pharmacotherapy. Pharmacol. Rep. 58 (2006) 159-178
4. Boger R.H. Asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, explains the "l-arginine paradox" and acts as a novel cardiovascular risk factor. J Nutr. 134 (2004) 2842S-2847S discussion 2853S
5. Booth B.P., Tabrizi-Fard M.A., and Fung H. Calcitonin gene-related peptide-dependent vascular relaxation of rat aorta. An additional mechanism for nitroglycerin. Biochem Pharmacol. 59 (2000) 1603-1609
6. Bouloumie A., Bauersachs J., Linz W., Scholkens B.A., Wiemer G., Fleming I., and Busse R. Endothelial dysfunction coincides with an enhanced nitric oxide synthase expression and superoxide anion production. Hypertension 30 (1997) 934-941
7. Brain S.D., and Grant A.D. Vascular actions of calcitonin gene-related peptide and adrenomedullin. Physiol. Rev. 84 (2004) 903-934
8. Brain S.D., MacIntyre I., and Williams T.J. A second form of human calcitonin gene-related peptide which is a potent vasodilator. Eur. J. Pharmacol. 124 (1986) 349-352
9. Chowdhary S., and Townend J.N. Nitric oxide and hypertension: not just an endothelium derived relaxing factor!. J. Hum. Hypertens. 15 (2001) 219-227
10. Deng P.Y., and Li Y.J. Calcitonin gene-related peptide and hypertension. Peptides 26 (2005) 1676-1685
11. Deng P.Y., Ye F., Cai W.J., Deng H.W., and Li Y.J. Role of calcitonin gene-related peptide in the phenol-induced neurogenic hypertension in rats. Regul. Pept. 119 (2004) 155-161
12. Deng P.Y., Ye F., Zhu H.Q., Cai W.J., Deng H.W., and Li Y.J. An increase in the synthesis and release of calcitonin gene-related peptide in two-kidney, one-clip hypertensive rats. Regul. Pept. 114 (2003) 175-182
13. Deng P.Y., Yu J., Ye F., Li D., Luo D., Cai W.J., Zhang J.W., Luo X.G., Deng H.W., and Li Y.J. Interactions of sympathetic nerves with capsaicin-sensitive sensory nerves: neurogenic mechanisms for phenol-induced hypertension in the rat. J. Hypertens. 23 (2005) 603-609
14. Durham P.L., Niemann C., and Cady R. Repression of stimulated calcitonin gene-related peptide secretion by topiramate. Headache 46 (2006) 1291-1295
15. Forte P., Copland M., Smith L.M., Milne E., Sutherland J., and Benjamin N. Basal nitric oxide synthesis in essential hypertension. Lancet 349 (1997) 837-842
16. Gangula P.R., Zhao H., Supowit S.C., Wimalawansa S.J., Dipette D.J., Westlund K.N., Gagel R.F., and Yallampalli C. Increased blood pressure in alpha-calcitonin gene-related peptide/calcitonin gene knockout mice. Hypertension 35 (2000) 470-475
17. Garry M.G., Richardson J.D., and Hargreaves K.M. Sodium nitroprusside evokes the release of immunoreactive calcitonin gene-related peptide and substance P from dorsal horn slices via nitric oxide-dependent and nitric oxide-independent mechanisms. J. Neurosci. 14 (1994) 4329-4337
18. Guzik T.J., Korbut R., and Adamek-Guzik T. Nitric oxide and superoxide in inflammation and immune regulation. J. Physiol. Pharmacol. 54 (2003) 469-487
19. Kajekar R., Moore P.K., and Brain S.D. Essential role for nitric oxide in neurogenic inflammation in rat cutaneous microcirculation. Evidence for an endothelium-independent mechanism. Circ. Res. 76 (1995) 441-447
20. Kelm M. The l-arginine-nitric oxide pathway in hypertension. Curr. Hypertens. Rep. 5 (2003) 80-86
21. Kielstein J.T., Impraim B., Simmel S., Bode-Boger S.M., Tsikas D., Frolich J.C., Hoeper M.M., Haller H., and Fliser D. Cardiovascular effects of systemic nitric oxide synthase inhibition with asymmetrical dimethylarginine in humans. Circulation 109 (2004) 172-177
22. Kuo J.J., Jones O.B., and Hall J.E. Inhibition of NO synthesis enhances chronic cardiovascular and renal actions of leptin. Hypertension 37 (2001) 670-676
23. Li, D., Peng, J., Xin, H.Y., Luo, D., Zhang, Y.S., Zhou, Z., Jiang, D.J., Deng, H.W., Li, Y.J., in press. Calcitonin gene-related peptide-mediated antihypertensive and anti-platelet effects by rutaecarpine in spontaneously hypertensive rats. Peptides [2008 Jun 25, Electronic publication ahead of print]
24. Li Z., and Duckles S.P. Acute effects of nicotine on rat mesenteric vasculature and tail artery. J. Pharmacol. Exp. Ther. 264 (1993) 1305-1310
25. Lu R., Zhu H.Q., Peng J., Li N.S., and Li Y.J. Endothelium-dependent vasorelaxation and the expression of calcitonin gene-related peptide in aged rats. Neuropeptides 36 (2002) 407-412
26. Luo D., Deng P.Y., Ye F., Peng W.J., Deng H.W., and Li Y.J. Delayed preconditioning by cardiac ischemia involves endogenous calcitonin gene-related peptide via the nitric oxide pathway. Eur. J. Pharmacol. 502 (2004) 135-141
27. Marquez-Rodas I., Longo F., Rothlin R.P., and Balfagon G. Pathophysiology and therapeutic possibilities of calcitonin gene-related peptide in hypertension. J. Physiol. Biochem. 62 (2006) 45-56
28. Martinez-Leon J.B., Segarra G., Medina P., Vila J.M., Lluch P., Peiro M., Otero E., and Lluch S. Ca2+-activated K+ channels mediate relaxation of forearm veins in chronic renal failure. J Hypertens 21 (2003) 1927-1934
29. Miao C.Y., Shen F.M., and Su D.F. Blood pressure variability is increased in genetic hypertension and L-NAME-induced hypertension. Acta Pharmacol. Sin. 22 (2001) 137-140
30. Naseem K.M. The role of nitric oxide in cardiovascular diseases. Mol. Aspects Med. 26 (2005) 33-65
31. Panza J.A., Quyyumi A.A., Brush J.E., and Epstein Jr. S.E. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N. Engl. J. Med. 323 (1990) 22-27
32. Peng J., Lu R., Deng H.W., and Li Y.J. Involvement of alpha-calcitonin gene-related peptide in monophosphoryl lipid A-induced delayed preconditioning in rat hearts. Eur. J. Pharmacol. 436 (2002) 89-96
33. Portaluppi F., Trasforini G., Margutti A., Vergnani L., Ambrosio M.R., Rossi R., Bagni B., Pansini R., and degli Uberti E.C. Circadian rhythm of calcitonin gene-related peptide in uncomplicated essential hypertension. J. Hypertens. 10 (1992) 1227-1234
34. Rosenfeld M.G., Mermod J.J., Amara S.G., Swanson L.W., Sawchenko P.E., Rivier J., Vale W.W., and Evans R.M. Production of a novel neuropeptide encoded by the calcitonin gene via tissue-specific RNA processing. Nature 304 (1983) 129-135
35. Scotland R.S., Chauhan S., Davis C., De Felipe C., Hunt S., Kabir J., Kotsonis P., Oh U., and Ahluwalia A. Vanilloid receptor TRPV1, sensory C-fibers, and vascular autoregulation: a novel mechanism involved in myogenic constriction. Circ. Res. 95 (2004) 1027-1034
36. Strecker T., Dux M., and Messlinger K. Nitric oxide releases calcitonin-gene-related peptide from rat dura mater encephali promoting increases in meningeal blood flow. J. Vasc. Res. 39 (2002) 489-496
37. Supowit S.C., Ramana C.V., Westlund K.N., and DiPette D.J. Calcitonin gene-related peptide gene expression in the spontaneously hypertensive rat. Hypertension 21 (1993) 1010-1014
38. Supowit S.C., Zhao H., Hallman D.M., and DiPette D.J. Calcitonin gene-related peptide is a depressor of deoxycorticosterone-salt hypertension in the rat. Hypertension 29 (1997) 945-950
39. Vallance P., Leone A., Calver A., Collier J., and Moncada S. Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet 339 (1992) 572-575
40. Wang D.H. The vanilloid receptor and hypertension. Acta Pharmacol. Sin. 26 (2005) 286-294
41. Wang Y., and Wang D.H. Neural control of blood pressure: focusing on capsaicin-sensitive sensory nerves. Cardiovasc. Hematol. Disord. Drug Targets 7 (2007) 37-46
42. Wimalawansa S.J. Calcitonin gene-related peptide and its receptors: molecular genetics, physiology, pathophysiology, and therapeutic potentials. Endocr. Rev. 17 (1996) 533-585
43. Zalba G., SanJose G., Moreno M.U., Fortuno M.A., Fortuno A., Beaumont F.J., and Diez J. Oxidative stress in arterial hypertension: role of NAD(P)H oxidase. Hypertension 38 (2001) 1395-1399
44. Zhou Z.H., Deng H.W., and Li Y.J. The depressor effect of nitroglycerin is mediated by calcitonin gene-related peptide. Life Sci 69 (2001) 1313-1320
45. Zhou Z.H., Peng J., Ye F., Li N.S., Deng H.W., and Li Y.J. Delayed cardioprotection induced by nitroglycerin is mediated by alpha-calcitonin gene-related peptide. Naunyn-Schmiedeberg's Arch. Pharmacol. 365 (2002) 253-259